Group One Trading’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.7K Sell
6,700
-12,900
-66% -$136K ﹤0.01% 5257
2025
Q4
$230K Sell
19,600
-53,300
-73% -$575K ﹤0.01% 4251
2025
Q3
$563K Sell
72,900
-25,400
-26% -$178K ﹤0.01% 3588
2025
Q2
$719K Buy
98,300
+500
+0.5% +$4.04K ﹤0.01% 3070
2025
Q1
$928K Buy
97,800
+18,100
+23% +$226K ﹤0.01% 2522
2024
Q4
$1.31M Buy
79,700
+54,900
+221% +$853K ﹤0.01% 2303
2024
Q3
$366K Sell
24,800
-10,600
-30% -$166K ﹤0.01% 3092
2024
Q2
$491K Sell
35,400
-86,100
-71% -$1.22M ﹤0.01% 2583
2024
Q1
$1.91M Sell
121,500
-31,300
-20% -$483K 0.01% 1510
2023
Q4
$2.47M Buy
152,800
+111,300
+268% +$1.82M 0.01% 1691
2023
Q3
$510K Sell
41,500
-1,800
-4% -$26.8K ﹤0.01% 2886
2023
Q2
$696K Buy
43,300
+15,400
+55% +$254K ﹤0.01% 2691
2023
Q1
$486K Buy
27,900
+5,900
+27% +$84K ﹤0.01% 2801
2022
Q4
$203K Sell
22,000
-3,900
-15% -$36.4K ﹤0.01% 3851
2022
Q3
$223K Sell
25,900
-2,600
-9% -$25.8K ﹤0.01% 4034
2022
Q2
$232K Sell
28,500
-44,000
-61% -$420K ﹤0.01% 4145
2022
Q1
$881K Buy
72,500
+22,600
+45% +$476K ﹤0.01% 3212
2021
Q4
$1.7M Buy
49,900
+17,800
+55% +$697K ﹤0.01% 2785
2021
Q3
$1.55M Sell
32,100
-26,600
-45% -$1.23M ﹤0.01% 2926
2021
Q2
$2.65M Sell
58,700
-7,000
-11% -$310K ﹤0.01% 2350
2021
Q1
$3.17M Sell
65,700
-9,200
-12% -$479K ﹤0.01% 1971
2020
Q4
$4.03M Sell
74,900
-25,200
-25% -$1.14M 0.01% 1451
2020
Q3
$3.69M Buy
100,100
+26,300
+36% +$978K 0.01% 1119
2020
Q2
$2.29M Buy
73,800
+27,600
+60% +$765K 0.01% 1375
2020
Q1
$1.28M Sell
46,200
-31,000
-40% -$929K 0.01% 1341
2019
Q4
$2.26M Sell
77,200
-18,200
-19% -$433K 0.02% 1200
2019
Q3
$1.82M Buy
95,400
+34,500
+57% +$809K 0.01% 1275
2019
Q2
$1.34M Sell
60,900
-34,000
-36% -$746K 0.01% 1383
2019
Q1
$1.94M Buy
94,900
+84,900
+849% +$1.48M 0.02% 948
2018
Q4
$126K Buy
+10,000
New +$149K ﹤0.01% 3026
2018
Q3
Sell
-5,300
Closed -$69K 5462
2018
Q2
$69K Sell
5,300
-56,400
-91% -$621K ﹤0.01% 3775
2018
Q1
$503K Sell
61,700
-400
-0.6% -$3.24K 0.01% 2064
2017
Q4
$550K Sell
62,100
-12,900
-17% -$119K ﹤0.01% 2175
2017
Q3
$835K Sell
75,000
-3,700
-5% -$36K 0.01% 1692
2017
Q2
$705K Sell
78,700
-11,400
-13% -$90.5K 0.01% 1712
2017
Q1
$711K Hold
90,100
0.01% 1593
2016
Q4
$772K Buy
90,100
+8,000
+10% +$68.5K 0.01% 1481
2016
Q3
$675K Sell
82,100
-1,900
-2% -$15.9K 0.01% 1581
2016
Q2
$675K Buy
84,000
+22,400
+36% +$180K 0.01% 1518
2016
Q1
$415K Sell
61,600
-15,900
-21% -$105K 0.01% 1811
2015
Q4
$610K Buy
77,500
+49,900
+181% +$365K 0.01% 1647
2015
Q3
$158K Buy
+27,600
New +$171K ﹤0.01% 2686
2015
Q2
Sell
-1,800
Closed -$8K 5043
2015
Q1
$8K Sell
1,800
-46,400
-96% -$202K ﹤0.01% 4227
2014
Q4
$201K Buy
48,200
+600
+1% +$2.76K ﹤0.01% 2305
2014
Q3
$248K Buy
+47,600
New +$245K ﹤0.01% 2208
2014
Q2
Sell
-400
Closed -$1K 5392
2014
Q1
$1K Sell
400
-200
-33% -$749 ﹤0.01% 5070
2013
Q4
$2K Buy
+600
New +$2.08K ﹤0.01% 5056

Other funds holding NEO

Group One Trading's NEO Position: Q1 2026 in Review

Group One Trading sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 3,847 shares — an estimated $40.5K sold.

Group One Trading first reported a position in NEO in Q4 2013 and held it in 11 quarters. The position peaked at $437K in Q3 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Group One Trading reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,847 NeoGenomics shares in Q1 2026, an estimated $40.5K.
  • Group One Trading first reported a position in NeoGenomics in Q4 2013 and held it in 11 quarters.
  • Group One Trading's NeoGenomics position peaked at $437K in Q3 2022.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.